Skip to main content
Top
Published in: Drugs & Aging 7/2014

01-07-2014 | Review Article

The Use of Estimated Glomerular Filtration Rate for Dose Adjustment of Medications in the Elderly

Authors: Carl-Gustaf Elinder, Peter Bárány, Olof Heimbürger

Published in: Drugs & Aging | Issue 7/2014

Login to get access

Abstract

Adverse drug effects as a consequence of inappropriate dosage are a common cause of hospitalization among the elderly. Older individuals are at a particular risk of overdosing because their kidney function decreases with advancing age and the elderly are often prescribed several pharmaceutical drugs. In addition, serum creatinine levels decrease owing to a reduction in muscle mass with age. Therefore, drug dosing based on the serum creatinine level only, instead of using assessment of the renal function, may result in overdosing of frail elderly patients. Renal function, i.e., the glomerular filtration rate can, with simple formulas, be estimated from analysis of creatinine and/or plasma cystatin C (eGFR). Such estimations performed with modern and validated formulas, as a rule present renal function normalized to the body surface area (mL/min/1.73 m2). A good estimation of how much the normal dosing interval should be prolonged, or the dose reduced, to obtain a desired plasma concentration of drugs that are mainly eliminated by glomerular filtration can be obtained by calculating the ratio between the patient’s eGFR and the normal renal function (about 90–125 mL/min/1.73 m2). Increased knowledge and use of eGFR by prescribing physicians will reduce the risk of overdosing drugs in the elderly.
Literature
1.
go back to reference Seyffart G. Seyffart’s directory of drug dosage in kidney disease. Oberhaching: Dustri-Verlag Dr. Karl Feistle; 2011. Seyffart G. Seyffart’s directory of drug dosage in kidney disease. Oberhaching: Dustri-Verlag Dr. Karl Feistle; 2011.
2.
go back to reference Blix HS, Viktil KK, Moger TA, Reikvam A. Use of renal risk drugs in hospitalized patients with impaired renal function: an underestimated problem? Nephrol Dial Transplant. 2006;21(11):3164–71. doi:10.1093/ndt/gfl399.PubMedCrossRef Blix HS, Viktil KK, Moger TA, Reikvam A. Use of renal risk drugs in hospitalized patients with impaired renal function: an underestimated problem? Nephrol Dial Transplant. 2006;21(11):3164–71. doi:10.​1093/​ndt/​gfl399.PubMedCrossRef
3.
go back to reference Corsonello A, Pedone C, Lattanzio F, Onder G, Antonelli Incalzi R. Association between glomerular filtration rate and adverse drug reactions in elderly hospitalized patients: the role of the estimating equation. Drugs Aging. 2011;28(5):379–90. doi:10.2165/11588280-000000000-000004.PubMedCrossRef Corsonello A, Pedone C, Lattanzio F, Onder G, Antonelli Incalzi R. Association between glomerular filtration rate and adverse drug reactions in elderly hospitalized patients: the role of the estimating equation. Drugs Aging. 2011;28(5):379–90. doi:10.​2165/​11588280-000000000-000004.PubMedCrossRef
4.
go back to reference Hug BL, Witkowski DJ, Sox CM, Keohane CA, Seger DL, Yoon C, et al. Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney. Kidney Int. 2009;76(11):1192–8. doi:10.1038/ki.2009.353.PubMedCrossRef Hug BL, Witkowski DJ, Sox CM, Keohane CA, Seger DL, Yoon C, et al. Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney. Kidney Int. 2009;76(11):1192–8. doi:10.​1038/​ki.​2009.​353.PubMedCrossRef
5.
go back to reference Hellden A, Odar-Cederlof I, Diener P, Barkholt L, Medin C, Svensson JO, et al. High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study. Nephrol Dial Transplant. 2003;18(6):1135–41.PubMedCrossRef Hellden A, Odar-Cederlof I, Diener P, Barkholt L, Medin C, Svensson JO, et al. High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study. Nephrol Dial Transplant. 2003;18(6):1135–41.PubMedCrossRef
6.
go back to reference SBU HTA. Methods to estimate and measure renal function (glomerular filtration rate): a systematic review. Report no: 214. Stockholm: Swedish Council on Health Technology Assessment; 2013. SBU HTA. Methods to estimate and measure renal function (glomerular filtration rate): a systematic review. Report no: 214. Stockholm: Swedish Council on Health Technology Assessment; 2013.
7.
go back to reference Soveri I, Berg UB, Björk J, Elinder CG, Grubb A, Mejare I, et al. Measuring glomerular filtration rate: a systematic review. Am J Kidney Dis. 2014 (in press). Soveri I, Berg UB, Björk J, Elinder CG, Grubb A, Mejare I, et al. Measuring glomerular filtration rate: a systematic review. Am J Kidney Dis. 2014 (in press).
8.
go back to reference Elinder CG, Ahlberg M, Allander SV, Alvestrand A, Asker-Hagelberg C, Bell M, et al. Methods to estimate and measure renal function (glomerular filtration rate). In: (SBU) SCoHTA, editor. A systematic review. Stockholm; 2013. Elinder CG, Ahlberg M, Allander SV, Alvestrand A, Asker-Hagelberg C, Bell M, et al. Methods to estimate and measure renal function (glomerular filtration rate). In: (SBU) SCoHTA, editor. A systematic review. Stockholm; 2013.
10.
go back to reference Evans M, van Stralen KJ, Schon S, Prutz KG, Stendahl M, Rippe B, et al. Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease. Nephrol Dial Transplant. 2013. doi:10.1093/ndt/gft226. Evans M, van Stralen KJ, Schon S, Prutz KG, Stendahl M, Rippe B, et al. Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease. Nephrol Dial Transplant. 2013. doi:10.​1093/​ndt/​gft226.
11.
go back to reference Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.PubMedCrossRef Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.PubMedCrossRef
12.
go back to reference Dubois D, Dubois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916;17:863–71.CrossRef Dubois D, Dubois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916;17:863–71.CrossRef
15.
go back to reference Thummel KE, Shen DD, Isoherranen N. Appendix II. Design and optimization of dosage regimens: pharmacokinetic data. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. New York: McGraw-Hill; 2011. Thummel KE, Shen DD, Isoherranen N. Appendix II. Design and optimization of dosage regimens: pharmacokinetic data. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. New York: McGraw-Hill; 2011.
16.
go back to reference Matzke GR, Aronoff GR, Atkinson AJ Jr, Bennett WM, Decker BS, Eckardt KU, et al. Drug dosing consideration in patients with acute and chronic kidney disease: a clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2011;80(11):1122–37. doi:10.1038/ki.2011.322ki2011322.PubMedCrossRef Matzke GR, Aronoff GR, Atkinson AJ Jr, Bennett WM, Decker BS, Eckardt KU, et al. Drug dosing consideration in patients with acute and chronic kidney disease: a clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2011;80(11):1122–37. doi:10.​1038/​ki.​2011.​322ki2011322.PubMedCrossRef
17.
18.
go back to reference Stevens LA, Nolin TD, Richardson MM, Feldman HI, Lewis JB, Rodby R, et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis. 2009;54(1):33–42. doi:10.1053/j.ajkd.2009.03.008. Stevens LA, Nolin TD, Richardson MM, Feldman HI, Lewis JB, Rodby R, et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis. 2009;54(1):33–42. doi:10.​1053/​j.​ajkd.​2009.​03.​008.
19.
go back to reference Hijazi Z, Hohnloser SH, Oldgren J, Andersson U, Connolly SJ, Eikelboom JW, et al. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY trial analysis. Circulation. 2013. doi:10.1161/CIRCULATIONAHA.113.003628. Hijazi Z, Hohnloser SH, Oldgren J, Andersson U, Connolly SJ, Eikelboom JW, et al. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY trial analysis. Circulation. 2013. doi:10.​1161/​CIRCULATIONAHA.​113.​003628.
20.
go back to reference Asker-Hagelberg C, Rydberg D, Hentschke M, Holm L, Rosenborg S, Elinder CG. Unclear on dose adjustment in renal impairment. Lakartidningen. 2013;110(21):1030–2.PubMed Asker-Hagelberg C, Rydberg D, Hentschke M, Holm L, Rosenborg S, Elinder CG. Unclear on dose adjustment in renal impairment. Lakartidningen. 2013;110(21):1030–2.PubMed
21.
go back to reference Nyman HA, Dowling TC, Hudson JQ, Peter WL, Joy MS, Nolin TD. Comparative evaluation of the Cockcroft–Gault equation and the Modification of Diet in Renal Disease (MDRD) study equation for drug dosing: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2011;31(11):1130–44. doi:10.1592/phco.31.11.1130.PubMedCrossRef Nyman HA, Dowling TC, Hudson JQ, Peter WL, Joy MS, Nolin TD. Comparative evaluation of the Cockcroft–Gault equation and the Modification of Diet in Renal Disease (MDRD) study equation for drug dosing: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2011;31(11):1130–44. doi:10.​1592/​phco.​31.​11.​1130.PubMedCrossRef
22.
23.
go back to reference McCullough K, Sharma P, Ali T, Khan I, Smith WC, MacLeod A, et al. Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. Nephrol Dial Transplant. 2012;27(5):1812–21. doi:10.1093/ndt/gfr547.PubMedCrossRef McCullough K, Sharma P, Ali T, Khan I, Smith WC, MacLeod A, et al. Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. Nephrol Dial Transplant. 2012;27(5):1812–21. doi:10.​1093/​ndt/​gfr547.PubMedCrossRef
Metadata
Title
The Use of Estimated Glomerular Filtration Rate for Dose Adjustment of Medications in the Elderly
Authors
Carl-Gustaf Elinder
Peter Bárány
Olof Heimbürger
Publication date
01-07-2014
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 7/2014
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-014-0187-z

Other articles of this Issue 7/2014

Drugs & Aging 7/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.